What one share of Sera Prognostics holds
We are a women’s health company utilizing our proprietary proteomics and bioinformatics platform, and significant data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
Sera Prognostics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.66 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.56 |
| Cash and investments | $1.59 |
| Book value | $1.18 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.02 | −$12.76 | $0.10 | −$10.94 | — | −$80.71 |
| 2021 | $0.01 | −$2.33 | $0.09 | −$2.20 | — | $9.24 |
| 2022 | $0.01 | −$1.43 | $0.03 | −$1.14 | — | $3.20 |
| 2023 | $0.01 | −$1.16 | $0.00 | −$0.88 | — | $2.25 |
| 2024 | $0.00 | −$0.99 | $0.00 | −$0.43 | — | $1.44 |
| 2025 | $0.00 | −$0.67 | $0.02 | −$0.55 | — | $1.58 |
Common questions about Sera Prognostics
How much does one share of Sera Prognostics earn?
Over the last 12 months, Sera Prognostics lost $0.66 for each share on $0.00 of sales.
Does Sera Prognostics pay a dividend?
Sera Prognostics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Sera Prognostics’s book value per share?
Sera Prognostics’s book value is $1.18 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Sera Prognostics have?
Each share of Sera Prognostics has $1.59 of cash and investments, as of June 30, 2026.
What is Sera Prognostics’s free cash flow per share?
−$0.56 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Sera Prognostics bought back shares?
Sera Prognostics’s share count rose about 2964% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.